A boost for Amgen's PBS-listed osteoporosis therapy PROLIA (denosumab), with the results of two studies backing its long-term use and efficacy over bisphosphonates. …
Latest Video
New Stories
-
Sanofi Ventures joins investors backing Australian radionuclide company
February 6, 2025 - - Australian Biotech -
'One believes things because one has been conditioned to believe them'
February 6, 2025 - - Latest News -
RFK Jr on the cusp of securing his nomination to lead the US health department
February 6, 2025 - - Latest News -
Omico calls for major government-industry support of fundamental change in cancer treatment
February 5, 2025 - - Latest News -
The mindset is that equitable access can only be achieved by denying everyone on the same basis
February 5, 2025 - - Latest News -
Baxter Kidney Care is now Vantive, a standalone organ therapy company
February 5, 2025 - - Latest News -
How is it fair that patients have no rights in this system of health technology assessment?
February 4, 2025 - - Latest News